But there have also been concerns about safety
Weight loss injections, particularly GLP-1 receptor agonists such as semaglutide (Wegovy) and liraglutide (Saxenda), are increasingly prescribed for weight management in the UK
The institute recommended that existing GLP-1 makers, and those with products in the pipeline, should consider steep discounts to prices in exchange for higher volume. What has to happen is we have to move from a low-volume, high-price business model, to a high-volume, low-price business model, Nunn said
Contact your credit card provider immediately to report potential fraud
But, this medicine does more than help you lose weight
The ultimate goal is to make losing weight feel second nature